Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-1.12 Mil
% of Total Estimate Gain
-24.83%

AlphaCrest Capital Management LLC's ACADIA Pharmaceuticals Inc Holding Summary

As of 2022-12-31, AlphaCrest Capital Management LLC held - shares of ACADIA Pharmaceuticals Inc(ACAD), totaling N/A. This investment constitutes 0% of their stock portfolio, and AlphaCrest Capital Management LLC now holds 0% of the outstanding ACADIA Pharmaceuticals Inc(ACAD) stock.

The initial trade took place in 2019Q3. And since then AlphaCrest Capital Management LLC has made 9 purchases of ACAD, at an average price of $30.39, for a total of 148,151.00 shares. In addition, there have been 5 sales at an average price of $22.84 for 148,151.00 shares. Based on historical transaction data and ACAD's current price of $22.57, AlphaCrest Capital Management LLC's estimated gain on his ACAD holdings is $-1.12 Mil, reflecting a -24.83% gain to date.

AlphaCrest Capital Management LLC ACAD ($22.57) Holding Chart

AlphaCrest Capital Management LLC ACAD ($22.57) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1